Welcome to the PART Study website. The PART Study is comparing radical prostatectomy and partial ablation (using HIFU) of the prostate in men with unilateral, intermediate risk prostate cancer. This is the first phase III study comparing these treatments and is funded by the NIHR HTA Programme. As a potential patient you can find more information relating to your diagnosis, download our Patient Information Leaflet and contact the PART Team if you have any questions. PART Study Investigators can navigate the ‘For the Research Team’ pages for further information relating to PART.

Participant Update
Recruitment Progress:
82
82
82
82